E
Keros Therapeutics, Inc. KROS
$11.58 $0.110.96%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024
Revenue 684.02% 948.65%
Total Other Revenue -- --
Total Revenue 684.02% 948.65%
Cost of Revenue -322.86% 21.50%
Gross Profit 330.86% -20.65%
SG&A Expenses 8.60% -1.42%
Depreciation & Amortization -- --
Other Operating Expenses -- --
Total Operating Expenses -4.66% 16.98%
Operating Income 9.21% -16.29%
Income Before Tax 13.65% -17.01%
Income Tax Expenses -- --
Earnings from Continuing Operations 13.09% -17.01%
Earnings from Discontinued Operations -- --
Extraordinary Item & Accounting Change -- --
Minority Interest in Earnings -- --
Net Income 13.09% -17.01%
EBIT 9.21% -16.29%
EBITDA 9.29% -16.38%
EPS Basic 19.01% -12.39%
Normalized Basic EPS 19.53% -12.38%
EPS Diluted 59.52% -124.87%
Normalized Diluted EPS 19.53% -12.38%
Average Basic Shares Outstanding 7.31% 4.12%
Average Diluted Shares Outstanding 7.31% 4.12%
Dividend Per Share -- --
Payout Ratio -- --
Weiss Ratings